The UK government-commissioned review, led by Professor Peter Fonagy, stated that medication should not be used to treat conditions like loneliness, recommending instead opportunities for young people to participate in socialising, work, and volunteering

Overview Debates Related claims Topics Sources

Relying on ChatGPT for friendship causes individuals to lose their perception of what a real human relationship is

Most capable adults are able to use AI chatbots in a healthy manner

Irresponsible use of artificial intelligence chatbots like ChatGPT poses a risk to users' mental health

Artificial intelligence chatbots can cause social isolation, particularly for individuals with social anxiety who choose to stay home and interact with artificial intelligence

Artificial intelligence chatbots like ChatGPT can be healthy for users if utilized correctly

Teenagers and Generation Z individuals are isolating themselves by treating ChatGPT as a friend and relying on ChatGPT to answer questions instead of talking to humans

Voice conversations with artificial intelligence chatbots can serve as training tools to help individuals with poor socialization skills practice and improve their communication abilities

Believing an artificial intelligence chatbot is an actual human being indicates a deeper psychological problem requiring professional help rather than being a flaw in the application

Some users perceive artificial intelligence chatbots as being like human beings

AI chatbots will increase emotional dependence and social isolation for some individuals

A placebo's psychological effect is driven by the patient's confidence in the medical professional and their belief that they are receiving a cure

A study of U.S. health records published in Lancet Psychiatry found that patients with both schizophrenia and type 2 diabetes who were prescribed GLP-1 receptor agonists had a 24% lower risk of psychiatric hospital admission than those not taking GLP-1s

Patients with schizophrenia and type 2 diabetes prescribed GLP-1 receptor agonists were 29% less likely to visit an emergency department for a mental health crisis compared to those not taking GLP-1s, according to a Lancet Psychiatry study

On 16 May, healthcare provider Keys Group acquired private neurodiversity clinic ADHD360 for £22.5 million while Samantha Jones held leadership roles and shares in Keys Group.

The Treatment-Resistant Depression Awareness Day campaign is supported by the National Alliance on Mental Illness, Mental Health America, and the Depression and Bipolar Support Alliance.

Compass Pathways announced the establishment of the first Treatment-Resistant Depression Awareness Day in the U.S. on October 14, 2026.

Former NIMH Director Steven Hyman warned at the STAT Summit that psychiatry lacks objective biomarkers to determine which patients will benefit from psychedelic treatments.

CDC Youth Mental Health Survey 2026 is a significant topic in the health domain with ongoing developments and regulatory implications.

Treatment-resistant depression is a significant topic in the health domain with ongoing developments and regulatory implications.

Psychiatric care access crisis and workforce shortages is a significant topic in the health domain with ongoing developments and regulatory implications.